Home > Books > Immunomodulating Drugs for the Treatment of Cancer
Immunomodulating Drugs for the Treatment of Cancer
View PDF

Immunomodulating Drugs for the Treatment of Cancer

Publication Year: 2011
Edition: 1st Ed.
Authors/Editor: Chanan-Khan, Asher A.
Publisher: Lippincott Williams & Wilkins (LWW)
ISBN: 978-1-605-47333-8
Doody's Star Rating®:  Score: 91
  • Description
  • Details
  • Collections

Immunomodulating Drugs for the Treatment of Cancer brings the most current information on these novel compounds to clinicians and scientists involved in the care of cancer patients.

Immunomodulatory (IMiDs) drugs are a new class of anticancer agents that has made a tremendous impact on the treatment of patients with various malignant diseases, including blood cancers and several cancers of the solid organs. Their popularity in prescribing is based on several important characteristics including: (1) oral bioavailability, (2) non-chemotherapeutic, (3) extremely well-tolerated in all age groups, (4) ability to activate patient's own immune response against cancer, (5) ease of combination with other agents such as chemotherapy resulting in higher responses as well as (6) variability of anticancer activity and a number of cancers. While there is a lot of literature published on these agents, unitl now there has been no textbook that provides a comprehensive resource for clinicians and researchers regarding these agents and their rapidly emerging role in cancer medicine.

The clinical applications of these agents are not limited to oncologists and hematologists, but also impact primary care doctors who care for these patients. Furthermore, new investigations are defining the role of these agents in non-malignant disorders as well.

  • Platform:
    Ovid
  • Publisher: Lippincott Williams & Wilkins (LWW)
  • Product Type: Book
  • Author/Editor: Chanan-Khan, Asher A.
  • ISBN: 978-1-605-47333-8
  • Specialty:
    Hematology
    Oncology
    Primary Care/Family Medicine/General Practice
  • Language: English
  • Edition: 1st Ed.
  • Pages: 312
  • Illustrations: 208
  • Year: 2011
  • Doody's Star Rating®:  Score: 91

Immunomodulating Drugs for the Treatment of Cancer is included in the following Collections:

Free Instant Access
This Month

JOTM
Embase® Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global biomedical research community.
JOTM
Food Science & Technology Abstracts FSTA® covers topics relating to every aspect of the food chain including all the major food commodities plus biotechnology, microbiology, food safety, additives, nutrition, packaging and pet foods.
JOTM
American Journal of Gastroenterology As the leading clinical journal covering gastroenterology and hepatology, AJG provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients.
JOTM
Evidence-Based Practice Evidence-Based Practice is a quarterly journal focused on topics relevant to the daily practice of family medicine and contains content addressing timely and pertinent questions related to patient care.

Noteworthy

Doody's Featured Books
Access Device Standards of Practice for Oncology Nursing
An essential resource for nurses practicing in a wide range of settings to ensure safe, effective care of patients with VADs.

Fundamentals of High-Resolution Lung CT: Common Findings, Common Patterns, Common Diseases, and Differential Diagnosis
Provides a straightforward guide to understanding the high-resolution lung CT (HRCT) assessment of diffuse lung diseases.